CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex assay (HIV 1/2, HBV and HCV), performed on the Tigris testing platform, to the -enhanced Ultrio Elite triplex assay performed on the Panther testing platform on July 13, 2020. The implementation date has been moved up to July 7th. Contact your Customer Service Manager if you have any questions!
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...